We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » PTAB Throws Out United Therapeutics Remodulin Patent in Win for SteadyMed
PTAB Throws Out United Therapeutics Remodulin Patent in Win for SteadyMed
The PTO’s Patent Trial and Appeal Board ruled in favor of SteadyMed in the drug manufacturer’s challenge to a patent held by United Therapeutics over its Remodulin blood pressure drug.